Selected research
Market Structure
Global Tumor Detection Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Tumor Detection Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Tumor Detection Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Tumor Detection Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Tumor Detection Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Tumor Detection Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Tumor Detection Services include Nonacus, Natera, Penn Medicine, Amadix, Oncologica, Rarecells, GRAIL, Elypta and Bio-Techne, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Tumor Detection Services market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Tumor Detection Services and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Tumor Detection Services revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Tumor Detection Services market size, projected growth trends, production technologies, key applications, and end-use industries.
Tumor Detection Services Segment by Company
Nonacus
Natera
Penn Medicine
Amadix
Oncologica
Rarecells
GRAIL
Elypta
Bio-Techne
iCAD
Dxcover
Caris Life Sciences
Novocure
Circulogene
Guardant Health
Veracyte
Haystack Oncology
Foundation Medicine
Tumor Detection Services Segment by Type
Non-Invasive Examination
Invasive Examination
Tumor Detection Services Segment by Application
Adults
Children
Tumor Detection Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tumor Detection Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tumor Detection Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tumor Detection Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Tumor Detection Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Tumor Detection Services industry.
Chapter 3: Detailed analysis of Tumor Detection Services companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Tumor Detection Servicesrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Non-Invasive Examination
- Invasive Examination
Applications
- Adults
- Children
Companies covered
- Nonacus
- Natera
- Penn Medicine
- Amadix
- Oncologica
- Rarecells
- GRAIL
- Elypta
- Bio-Techne
- iCAD
- Dxcover
- Caris Life Sciences
- Novocure
- Circulogene
- Guardant Health
- Veracyte
- Haystack Oncology
- Foundation Medicine
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Tumor Detection Services Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Non-Invasive Examination
- 1.2.3 Invasive Examination
- 1.3 Market Analysis by Application
- 1.3.1 Global Tumor Detection Services Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Adults
- 1.3.3 Children
- 1.4 Global Market Growth Prospects
- 1.5 Global Tumor Detection Services Growth Trends by Region
- 1.5.1 Global Tumor Detection Services Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Tumor Detection Services Market Size by Region (2021-2026)
- 1.5.3 Tumor Detection Services Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Tumor Detection Services Market Dynamics
- 2.1 Tumor Detection Services Industry Trends
- 2.2 Tumor Detection Services Industry Drivers
- 2.3 Tumor Detection Services Industry Opportunities and Challenges
- 2.4 Tumor Detection Services Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Tumor Detection Services Revenue by Company (2021-2026)
- 3.2 Global Tumor Detection Services Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Tumor Detection Services Key Company Head office and Area Served
- 3.4 Global Tumor Detection Services Company, Product Type & Application
- 3.5 Global Tumor Detection Services Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Tumor Detection Services Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Tumor Detection Services Players Market Share by Revenue in 2025
- 3.6.3 2025 Tumor Detection Services Tier 1, Tier 2, and Tier 3
4 Tumor Detection Services Market by Type
- 4.1 Global Tumor Detection Services Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Tumor Detection Services Market Size by Type (2021-2032)
- 4.3 Global Tumor Detection Services Market Size Share by Type (2021-2032)
5 Tumor Detection Services Market by Application
- 5.1 Global Tumor Detection Services Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Tumor Detection Services Market Size by Application (2021-2032)
- 5.3 Global Tumor Detection Services Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Nonacus
- 6.1.1 Nonacus Company Information
- 6.1.2 Nonacus Business Overview
- 6.1.3 Nonacus Tumor Detection Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Nonacus Tumor Detection Services Product Portfolio
- 6.1.5 Nonacus Recent Developments
- 6.2 Natera
- 6.2.1 Natera Company Information
- 6.2.2 Natera Business Overview
- 6.2.3 Natera Tumor Detection Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Natera Tumor Detection Services Product Portfolio
- 6.2.5 Natera Recent Developments
- 6.3 Penn Medicine
- 6.3.1 Penn Medicine Company Information
- 6.3.2 Penn Medicine Business Overview
- 6.3.3 Penn Medicine Tumor Detection Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Penn Medicine Tumor Detection Services Product Portfolio
- 6.3.5 Penn Medicine Recent Developments
- 6.4 Amadix
- 6.4.1 Amadix Company Information
- 6.4.2 Amadix Business Overview
- 6.4.3 Amadix Tumor Detection Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Amadix Tumor Detection Services Product Portfolio
- 6.4.5 Amadix Recent Developments
- 6.5 Oncologica
- 6.5.1 Oncologica Company Information
- 6.5.2 Oncologica Business Overview
- 6.5.3 Oncologica Tumor Detection Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Oncologica Tumor Detection Services Product Portfolio
- 6.5.5 Oncologica Recent Developments
- 6.6 Rarecells
- 6.6.1 Rarecells Company Information
- 6.6.2 Rarecells Business Overview
- 6.6.3 Rarecells Tumor Detection Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Rarecells Tumor Detection Services Product Portfolio
- 6.6.5 Rarecells Recent Developments
- 6.7 GRAIL
- 6.7.1 GRAIL Company Information
- 6.7.2 GRAIL Business Overview
- 6.7.3 GRAIL Tumor Detection Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 GRAIL Tumor Detection Services Product Portfolio
- 6.7.5 GRAIL Recent Developments
- 6.8 Elypta
- 6.8.1 Elypta Company Information
- 6.8.2 Elypta Business Overview
- 6.8.3 Elypta Tumor Detection Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Elypta Tumor Detection Services Product Portfolio
- 6.8.5 Elypta Recent Developments
- 6.9 Bio-Techne
- 6.9.1 Bio-Techne Company Information
- 6.9.2 Bio-Techne Business Overview
- 6.9.3 Bio-Techne Tumor Detection Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Bio-Techne Tumor Detection Services Product Portfolio
- 6.9.5 Bio-Techne Recent Developments
- 6.10 iCAD
- 6.10.1 iCAD Company Information
- 6.10.2 iCAD Business Overview
- 6.10.3 iCAD Tumor Detection Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 iCAD Tumor Detection Services Product Portfolio
- 6.10.5 iCAD Recent Developments
- 6.11 Dxcover
- 6.11.1 Dxcover Company Information
- 6.11.2 Dxcover Business Overview
- 6.11.3 Dxcover Tumor Detection Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Dxcover Tumor Detection Services Product Portfolio
- 6.11.5 Dxcover Recent Developments
- 6.12 Caris Life Sciences
- 6.12.1 Caris Life Sciences Company Information
- 6.12.2 Caris Life Sciences Business Overview
- 6.12.3 Caris Life Sciences Tumor Detection Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Caris Life Sciences Tumor Detection Services Product Portfolio
- 6.12.5 Caris Life Sciences Recent Developments
- 6.13 Novocure
- 6.13.1 Novocure Company Information
- 6.13.2 Novocure Business Overview
- 6.13.3 Novocure Tumor Detection Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Novocure Tumor Detection Services Product Portfolio
- 6.13.5 Novocure Recent Developments
- 6.14 Circulogene
- 6.14.1 Circulogene Company Information
- 6.14.2 Circulogene Business Overview
- 6.14.3 Circulogene Tumor Detection Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Circulogene Tumor Detection Services Product Portfolio
- 6.14.5 Circulogene Recent Developments
- 6.15 Guardant Health
- 6.15.1 Guardant Health Company Information
- 6.15.2 Guardant Health Business Overview
- 6.15.3 Guardant Health Tumor Detection Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 Guardant Health Tumor Detection Services Product Portfolio
- 6.15.5 Guardant Health Recent Developments
- 6.16 Veracyte
- 6.16.1 Veracyte Company Information
- 6.16.2 Veracyte Business Overview
- 6.16.3 Veracyte Tumor Detection Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.16.4 Veracyte Tumor Detection Services Product Portfolio
- 6.16.5 Veracyte Recent Developments
- 6.17 Haystack Oncology
- 6.17.1 Haystack Oncology Company Information
- 6.17.2 Haystack Oncology Business Overview
- 6.17.3 Haystack Oncology Tumor Detection Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.17.4 Haystack Oncology Tumor Detection Services Product Portfolio
- 6.17.5 Haystack Oncology Recent Developments
- 6.18 Foundation Medicine
- 6.18.1 Foundation Medicine Company Information
- 6.18.2 Foundation Medicine Business Overview
- 6.18.3 Foundation Medicine Tumor Detection Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.18.4 Foundation Medicine Tumor Detection Services Product Portfolio
- 6.18.5 Foundation Medicine Recent Developments
7 North America
- 7.1 North America Tumor Detection Services Market Size (2021-2032)
- 7.2 North America Tumor Detection Services Market Size by Type
- 7.2.1 North America Tumor Detection Services Market Size by Type (2021-2026)
- 7.2.2 North America Tumor Detection Services Market Size by Type (2027-2032)
- 7.2.3 North America Tumor Detection Services Market Share by Type (2021-2032)
- 7.3 North America Tumor Detection Services Market Size by Application
- 7.3.1 North America Tumor Detection Services Market Size by Application (2021-2026)
- 7.3.2 North America Tumor Detection Services Market Size by Application (2027-2032)
- 7.3.3 North America Tumor Detection Services Market Share by Application (2021-2032)
- 7.4 North America Tumor Detection Services Market Size by Country
- 7.4.1 North America Tumor Detection Services Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Tumor Detection Services Market Size by Country (2021-2026)
- 7.4.3 North America Tumor Detection Services Market Size by Country (2027-2032)
- 7.4.4 North America Tumor Detection Services Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Tumor Detection Services Market Size (2021-2032)
- 8.2 Europe Tumor Detection Services Market Size by Type
- 8.2.1 Europe Tumor Detection Services Market Size by Type (2021-2026)
- 8.2.2 Europe Tumor Detection Services Market Size by Type (2027-2032)
- 8.2.3 Europe Tumor Detection Services Market Share by Type (2021-2032)
- 8.3 Europe Tumor Detection Services Market Size by Application
- 8.3.1 Europe Tumor Detection Services Market Size by Application (2021-2026)
- 8.3.2 Europe Tumor Detection Services Market Size by Application (2027-2032)
- 8.3.3 Europe Tumor Detection Services Market Share by Application (2021-2032)
- 8.4 Europe Tumor Detection Services Market Size by Country
- 8.4.1 Europe Tumor Detection Services Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Tumor Detection Services Market Size by Country (2021-2026)
- 8.4.3 Europe Tumor Detection Services Market Size by Country (2027-2032)
- 8.4.4 Europe Tumor Detection Services Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Tumor Detection Services Market Size (2021-2032)
- 9.2 China Tumor Detection Services Market Size by Type
- 9.2.1 China Tumor Detection Services Market Size by Type (2021-2026)
- 9.2.2 China Tumor Detection Services Market Size by Type (2027-2032)
- 9.2.3 China Tumor Detection Services Market Share by Type (2021-2032)
- 9.3 China Tumor Detection Services Market Size by Application
- 9.3.1 China Tumor Detection Services Market Size by Application (2021-2026)
- 9.3.2 China Tumor Detection Services Market Size by Application (2027-2032)
- 9.3.3 China Tumor Detection Services Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Tumor Detection Services Market Size (2021-2032)
- 10.2 Asia Tumor Detection Services Market Size by Type
- 10.2.1 Asia Tumor Detection Services Market Size by Type (2021-2026)
- 10.2.2 Asia Tumor Detection Services Market Size by Type (2027-2032)
- 10.2.3 Asia Tumor Detection Services Market Share by Type (2021-2032)
- 10.3 Asia Tumor Detection Services Market Size by Application
- 10.3.1 Asia Tumor Detection Services Market Size by Application (2021-2026)
- 10.3.2 Asia Tumor Detection Services Market Size by Application (2027-2032)
- 10.3.3 Asia Tumor Detection Services Market Share by Application (2021-2032)
- 10.4 Asia Tumor Detection Services Market Size by Country
- 10.4.1 Asia Tumor Detection Services Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Tumor Detection Services Market Size by Country (2021-2026)
- 10.4.3 Asia Tumor Detection Services Market Size by Country (2027-2032)
- 10.4.4 Asia Tumor Detection Services Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Tumor Detection Services Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Tumor Detection Services Market Size by Type
- 11.2.1 South America, Middle East & Africa Tumor Detection Services Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Tumor Detection Services Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Tumor Detection Services Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Tumor Detection Services Market Size by Application
- 11.3.1 South America, Middle East & Africa Tumor Detection Services Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Tumor Detection Services Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Tumor Detection Services Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Tumor Detection Services Market Size by Country
- 11.4.1 South America, Middle East & Africa Tumor Detection Services Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Tumor Detection Services Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Tumor Detection Services Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Tumor Detection Services Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst